This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA’s life sciences litigation support services are grounded in a comprehensive understanding of pharmaceutical, biotechnology, medical device, and diagnostic markets. For more than 30 years, our experts have consulted with major life science companies, law firms, and regulatory agencies around the globe. We provide clients with the industry and analytical expertise needed to solve our clients’ most complex issues.
CRA has a reputation for delivering rigorous analysis and expert testimony. Economic expertise is complemented by experience assisting life sciences companies with business and policy issues. This combination allows CRA to provide effective expert testimony and support.
Group Vice President and Life Sciences Practice Leader
Boston
+1-617-425-3357 gbell@crai.comAttendees and panelists unpacked recent Executive Orders (EOs) in US legal responses and considered future implications for the life sciences sector. CRA’s...
However, expert evidence on economic issues is likely to become increasingly important for UPC proceedings in the near term. CRA consultants Andrew Tepperman,...
CRA is a proud sponsor of the conference that aims to increase the prominence of women through professional development, substantive legal discussion, and...
Archan Ruparel presents the session providing an overview of the fundamentals of antitrust economics. The webinar is art of the ABA Antitrust Summer Series, a...
